cancer research - An Overview
An improved Biomarker for Cancer Immunotherapy? Posted: November 3, 2023 A whole new review, executed mostly in mice, may perhaps aid describe why a at the moment employed molecular marker—named mismatch maintenance deficiency—doesn’t often perform to forecast which sufferers will respond to immunotherapies termed immune checkpoint inhibitors